KRASG12C inhibition with sotorasib in advanced solid tumors

Authors

David S. Hong, The University of Texas MD Anderson Cancer Center
Ramaswamy Govindan, Washington University School of Medicine in St. Louis
et al

Journal

The New England Journal of Medicine

Publication Date

2020

Volume

383

Issue

13

First Page

1207

Last Page

1217

Document Type

Open Access Publication

DOI

10.1056/NEJMoa1917239

Rights and Permissions

Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, Falchook GS, Price TJ, Sacher A, Denlinger CS, Bang YJ, Dy GK, Krauss JC, Kuboki Y, Kuo JC, Coveler AL, Park K, Kim TW, Barlesi F, Munster PN, Ramalingam SS, Burns TF, Meric-Bernstam F, Henary H, Ngang J, Ngarmchamnanrith G, Kim J, Houk BE, Canon J, Lipford JR, Friberg G, Lito P, Govindan R, Li BT. KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors. N Engl J Med. 2020 Sep 24;383(13):1207-1217. doi: 10.1056/NEJMoa1917239 Copyright © 2020 Massachusetts Medical Society. All rights reserved. https://www.nejm.org/doi/10.1056/NEJMoa1917239?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Recommended Citation

Hong, David S.; Govindan, Ramaswamy; and al, et, "KRASG12C inhibition with sotorasib in advanced solid tumors." The New England Journal of Medicine. 383, 13. 1207 - 1217. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/10696